Elanco Animal Health Incorporated (NYSE: ELAN), announced today a new global R&D collaboration with AgBiome, Inc. to develop nutritional health products for swine. The collaboration further demonstrates Elanco’s commitment to antibiotic stewardship and bringing alternatives […]
Investment in the company’s microbiome platform will propel the global launch of breakthrough products for livestock, companion animal and human health: MicroSintesis, a life science company focused on developing proprietary microbiome therapies today, at the Vet […]
DayTwo, the microbiome human discovery platform that offers a glycemic control solution for people with type 2 diabetes, announced $31 Million in Series B financing. DayTwo will use the funding to accelerate go-to-market initiatives in […]
The human microbiome, the vast collection of microbes that colonize the surfaces lining many of our organs and our skin – is a critical pillar sustaining our general health. At any one time, 500 to […]
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted therapeutics for neurodegenerative diseases and neurodevelopmental disorders, announced a direct investment of $10 million from Taiho Ventures, LLC to fund the discovery […]
OxThera AB, a biopharmaceutical company dedicated to improve the lives of people living with Primary Hyperoxaluria, today announced that the first patients in a Phase 3 study of Oxabact® have completed the study and transitioned […]
Parkinson’s Disease (PD) is characterized by a loss of dopaminergic neurons and intraneural accumulation of alpha-synuclein, including in the gut. Neuroinflammation and oxidation may favor alpha-syn aggregation which may in turn increase pro-inflammatory cytokines and […]
DermBiont, a clinical stage therapeutics company dedicated to the discovery and development of live bacterial products for the treatment of skin diseases has closed an $8M Series A. The funding round was led by Zola […]
Intralytix, Inc., announced today that is has entered into a joint collaboration agreement with the Eliava Foundation and Ferring Pharmaceuticals to develop and commercialize new and innovative bacteriophage-based drugs in the field of Reproductive Medicine […]
The first time Vayu Maini Rekdal manipulated microbes, he made a decent sourdough bread. At the time, young Maini Rekdal, and most people who head to the kitchen to whip up a salad dressing, pop […]
The Food and Drug Administration (FDA) issued an Important Safety Alert regarding the use of FMT and risk of serious adverse reactions due to transmission of Multi-Drug Resistant Organisms. The Alert was issued after two immunocompromised adults […]